{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:49:35Z","timestamp":1782103775324,"version":"3.54.5"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Rosacea is a chronic inflammatory dermatological condition predominantly affecting the facial region. Clinically, rosacea is characterized by paroxysmal flushing, persistent erythema, telangiectasia, papules, pustules, and ocular symptoms. Severe rosacea cases are frequently complicated by anxiety, depression, and sleep disturbances, imposing a heavy psychosocial burden and markedly impairing the quality of life of the patients. Abnormal activation of the neuro-vascular-immune triad has been reported as a crucial pathological mechanism of rosacea. Moreover, dysregulation within the central nervous system might exacerbate disease progression by modulating peripheral nerve activity and neuroendocrine homeostasis. In this review, we summarize the latest advancements in rosacea treatments targeting the neuro-vascular-immune triad, including \u03b3-aminobutyric acid derivatives, antidepressants, anti-calcitonin gene-related peptide agents, physical neuromodulation (transcutaneous auricular vagus nerve and repetitive transcranial magnetic stimulations), botulinum toxin type A, and \u03b2-blockers. We provide a comprehensive analysis of their molecular mechanisms, clinical efficacy, and current limitations. While such therapies could specifically regulate different stages of the pathway, their evidence lacks large-scale randomized controlled trials and clarity regarding optimal dosing regimens and treatment durations. Future studies should strengthen basic investigations and clinical translation, explore combined therapeutic strategies, as well as develop personalized therapeutic strategies for the long-term effective control of rosacea.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1876564","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:34:44Z","timestamp":1782102884000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic progress in rosacea: targeting the neuro-vascular-immune triad"],"prefix":"10.3389","volume":"17","author":[{"given":"Xingyin","family":"Yang","sequence":"first","affiliation":[{"name":"The Second Clinical Medical College of Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, the First Affiliated Hospital with Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuoran","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, the First Affiliated Hospital with Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dansheng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Beilun People\u2019s Hospital","place":["Ningbo, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, the First Affiliated Hospital with Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.12.038","article-title":"Epidemiology of acne and rosacea: A worldwide global study","volume":"90","author":"Saurat","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17411","article-title":"Rosacea in east asian populations: Clinical manifestations and pathophysiological perspectives for accurate diagnosis","volume":"51","author":"Nobeyama","year":"2024","journal-title":"J Dermatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16481","article-title":"Incidence and prevalence of rosacea: A systematic review and meta-analysis","volume":"179","author":"Gether","year":"2018","journal-title":"Br J Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00605-w","article-title":"Clinical features and risk factors for nasal rosacea: A hospital-based retrospective study","volume":"11","author":"Wu","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14039","article-title":"Characterization of rosacea in chinese: An analysis of 254 cases","volume":"20","author":"Chang","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2021.12.008","article-title":"Association of rosacea with depression and anxiety: A systematic review and meta-analysis","volume":"299","author":"Chang","year":"2022","journal-title":"J Affect Disord"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26052366","article-title":"Managing a burning face: Clinical manifestations and therapeutic approaches for neurogenic rosacea","volume":"26","author":"Aedo","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B8","volume-title":"The Oxford 2011 Levels of Evidence: Oxford Centre for Evidence-Based Medicine","year":"2011"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S571037","article-title":"Uvb upregulates inflammatory cytokines in rosacea cell model by promoting the expression of trpvs and tlr2","volume":"15","author":"Xie","year":"2026","journal-title":"Immunotargets Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.424","article-title":"Distribution and expression of non-neuronal transient receptor potential (trpv) ion channels in rosacea","volume":"132","author":"Sulk","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.16537.1","article-title":"Recent advances in understanding and managing rosacea","volume":"7","author":"Buddenkotte","year":"2018","journal-title":"F1000Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.222","article-title":"Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea","volume":"134","author":"Muto","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.191","article-title":"Activation of transient receptor potential ankyrin 1 induces cgrp release from spinal cord synaptosomes","volume":"3","author":"Quallo","year":"2015","journal-title":"Pharmacol Res Perspect"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2008.08.037","article-title":"Phosphorylation of trpv1 by neurokinin-1 receptor agonist exaggerates the capsaicin-mediated substance p release from cultured rat dorsal root ganglion neurons","volume":"55","author":"Tang","year":"2008","journal-title":"Neuropharmacology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173205","article-title":"The effects of cgrp in vascular tissue - classical vasodilation, shadowed effects and systemic dilemmas","volume":"881","author":"Sohn","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nm1616","article-title":"Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Yamasaki","year":"2007","journal-title":"Nat Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.351","article-title":"Tlr2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes","volume":"131","author":"Yamasaki","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13143","article-title":"Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics","volume":"26","author":"Holmes","year":"2017","journal-title":"Exp Dermatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20249","article-title":"Beyond the classic players: Mas-related g protein-coupled receptor member x2 role in pruritus and skin diseases","volume":"39","author":"Kumar","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(90)90176-a","article-title":"Mast cells as a source of multifunctional cytokines","volume":"11","author":"Gordon","year":"1990","journal-title":"Immunol Today"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132367","article-title":"Histamine induces vascular hyperpermeability by increasing blood flow and endothelial barrier disruption in vivo","volume":"10","author":"Ashina","year":"2015","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jaci.2021.03.049","article-title":"Multifaceted mrgrpx2: New insight into the role of mast cells in health and disease","volume":"148","author":"Roy","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12979-025-00536-6","article-title":"Vitamin d and the aging skin: Insights into oxidative stress, inflammation, and barrier function","volume":"22","author":"Gao","year":"2025","journal-title":"Immun Ageing"},{"key":"B24","first-page":"1","article-title":"Acne rosacea significantly affects quality of life","volume":"3","author":"Franji\u0107","year":"2025","journal-title":"Int J Nurs Care"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/srt.13171","article-title":"Identifying the neural basis for rosacea using positron emission tomography-computed tomography cerebral functional imaging analysis: A cross-sectional study","volume":"28","author":"Liu","year":"2022","journal-title":"Skin Res Technol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S413237","article-title":"New insights into the mutual promotion of rosacea, anxiety, and depression from neuroendocrine immune aspects","volume":"16","author":"Yang","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.70048","article-title":"Rosacea and migraine: A systematic review and meta-analysis update","volume":"65","author":"Mordehachvili Burla","year":"2026","journal-title":"Int J Dermatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17012","article-title":"Increased risk of sleep disturbances in patients with rosacea: A nationwide population-based cohort study","volume":"51","author":"Chae","year":"2024","journal-title":"J Dermatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jocn.2020.03.005","article-title":"Neuroinflammation and depressive disorder: The role of the hypothalamus","volume":"75","author":"Cernackova","year":"2020","journal-title":"J Clin Neurosci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.5070\/d3262047430","article-title":"The role of hypothalamus-pituitary-adrenal (hpa)-like axis in inflammatory pilosebaceous disorders","volume":"26","author":"Saric-Bosanac","year":"2020","journal-title":"Dermatol Online J"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abe0337","article-title":"Keratinocytes control skin immune homeostasis through de novo-synthesized glucocorticoids","volume":"7","author":"Phan","year":"2021","journal-title":"Sci Adv"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13084","article-title":"Cannabinoid and vanilloid pathways mediate opposing forms of synaptic plasticity in corticotropin-releasing hormone neurons","volume":"34","author":"Jamieson","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/life12050725","article-title":"The trinity of skin: Skin homeostasis as a neuro-endocrine-immune organ","volume":"12","author":"Jin","year":"2022","journal-title":"Life (Basel)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S550614","article-title":"Updates in the treatment of rosacea with gamma-aminobutyric acid derivatives","volume":"18","author":"Li","year":"2025","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-026-09662-3","article-title":"Transcriptomic and metabolomic insights into gabapentin's therapeutic role in neurogenic inflammation of rosacea","volume":"9","author":"Jiang","year":"2026","journal-title":"Commun Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.12.003","article-title":"Gabapentin improves the flushing of rosacea, but not other rosacea symptoms or quality of life: Results from a multicenter, randomized, double-blind, placebo-controlled pilot study","volume":"92","author":"Ma","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.12.011","article-title":"Gabapentin is an efficacy treatment for facial flushing and erythema of erythematotelangiectatic rosacea: A randomized clinical noninferiority trial","volume":"92","author":"Wei","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2022.09.016","article-title":"Neurogenic rosacea successfully treated with neuromodulators and intense pulsed light","volume":"99","author":"Hurtado","year":"2024","journal-title":"Bras Dermatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/1346-8138.15629","article-title":"Neurogenic rosacea in korea","volume":"48","author":"Kim","year":"2021","journal-title":"J Dermatol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41392-024-01738-y","article-title":"Major depressive disorder: Hypothesis, mechanism, prevention and treatment","volume":"9","author":"Cui","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00403-025-03982-w","article-title":"Exploring the psychodermatologic burden and associated psychiatric manifestations in rosacea: A systemic review","volume":"317","author":"Sharifi","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-023-06308-8","article-title":"Liposaccharide-induced sustained mild inflammation fragments social behavior and alters basolateral amygdala activity","volume":"240","author":"Loh","year":"2023","journal-title":"Psychopharmacol (Berl)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.01.044","article-title":"Paroxetine is an effective treatment for refractory erythema of rosacea: Primary results from the prospective rosacea refractory erythema randomized clinical trial","volume":"88","author":"Wang","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.13479\/j.cnki.jip.2023.06.010","article-title":"Effect of paroxetine hydrochloride on anxiety and depression and the level of monoamine neurotransmitter in the mild to moderate rosacea patients complicated with depression","volume":"50","author":"Chang","year":"2023","journal-title":"J Int Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.13735\/j.cjdv.1001-7089.201812057","article-title":"Effects of duloxetine hydrochloride on rosacne and depression","volume":"33","author":"Wu","year":"2019","journal-title":"Chin J Dermatovenereology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.13479\/j.cnki.jip.2022.04.020","article-title":"Effect of duloxetine hydrochloride on anxiety and depression in rosacea patients and its effect on cellular immune balance","volume":"49","author":"Zhou","year":"2022","journal-title":"J Int Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19954","article-title":"Elevated plasma levels of calcitonin gene-related peptide in individuals with rosacea: A cross-sectional case-control study","volume":"39","author":"Wienholtz","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00109-6","article-title":"Calcitonin gene-related peptide-targeted therapy in migraine: Current role and future perspectives","volume":"405","author":"Versijpt","year":"2025","journal-title":"Lancet"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljad277","article-title":"An exploratory comparative case series of calcitonin gene-related peptide monoclonal antibodies in patients with migraine with rosacea","volume":"189","author":"Sia","year":"2023","journal-title":"Br J Dermatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2024.0408","article-title":"Erenumab for treatment of persistent erythema and flushing in rosacea: A nonrandomized controlled trial","volume":"160","author":"Wienholtz","year":"2024","journal-title":"JAMA Dermatol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"7265","DOI":"10.1038\/s41467-024-50970-1","article-title":"High-sensitive sensory neurons exacerbate rosacea-like dermatitis in mice by activating gammadelta T cells directly","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat Commun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.8880","article-title":"Exploring the potential dermatological benefits of CGRP inhibition: A case report","volume":"24","author":"Burke","year":"2025","journal-title":"J Drugs Dermatol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.1097\/JS9.0000000000001592","article-title":"Transcutaneous auricular vagus nerve stimulation as a novel therapy connecting the central and peripheral systems: A review","volume":"110","author":"Zou","year":"2024","journal-title":"Int J Surg"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.25259\/IJDVL_1282_2024","article-title":"Transcutaneous auricular vagus nerve stimulation treatment for cutaneous dirt-adherent disease complicated with rosacea","author":"Wei","year":"2024","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2025.3796","article-title":"Transcutaneous auricular vagus nerve stimulation treatment for erythematotelangiectatic rosacea: A randomized clinical trial","volume":"161","author":"Li","year":"2025","journal-title":"JAMA Dermatol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.clinph.2019.11.002","article-title":"Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018)","volume":"131","author":"Lefaucheur","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2022.101735","article-title":"Repetitive transcranial magnetic stimulation in primary sleep disorders","volume":"67","author":"Lanza","year":"2023","journal-title":"Sleep Med Rev"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20240859","article-title":"Treating depression with repetitive transcranial magnetic stimulation: A clinician's guide","volume":"182","author":"Chen","year":"2025","journal-title":"Am J Psychiatry"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljaf359","article-title":"Repetitive transcranial magnetic stimulation targeting the right dorsolateral prefrontal cortex for the treatment of erythematotelangiectatic rosacea","volume":"193","author":"Song","year":"2025","journal-title":"Br J Dermatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2025.06.040","article-title":"Efficacy and safety of repetitive transcranial magnetic stimulation in treating erythematotelangiectatic rosacea: A single-center, randomized, double-blind, sham-controlled device trial","volume":"93","author":"Zhang","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1600921","article-title":"Effect of transcranial magnetic stimulation combined with transcutaneous auricular vagus nerve stimulation on mild cognitive impairment: A study protocol for a randomized controlled trial","volume":"17","author":"Zhang","year":"2025","journal-title":"Front Aging Neurosci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.5021\/ad.24.171","article-title":"The anti-angiogenic effect of microbotox on rosacea is due to the suppressed secretion of VEGF by mast cells resulting from internalization of the MRGPRX2 receptor","volume":"37","author":"Wan","year":"2025","journal-title":"Ann Dermatol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15395","article-title":"A randomized, controlled, split-face study of botulinum toxin and broadband light for the treatment of erythematotelangiectatic rosacea","volume":"35","author":"Tong","year":"2022","journal-title":"Dermatol Ther"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000004528","article-title":"Effects of botulinum toxin type A treatment on clinical and biophysical parameters in patients with erythematotelangiectatic rosacea: A prospective, randomized, controlled, double-blind study","volume":"51","author":"Dagtas","year":"2025","journal-title":"Dermatol Surg"},{"key":"B65","doi-asserted-by":"publisher","first-page":"16","DOI":"10.35541\/cjd.20220390","article-title":"Expert consensus on intradermal injections with botulinum toxin A for the treatment of flushing and persistent erythema caused by rosacea","volume":"56","author":"Li","year":"2023","journal-title":"Chin J Dermatol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.04.129","article-title":"Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action","volume":"83","author":"Logger","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.609615","article-title":"A novel mechanism of carvedilol efficacy for rosacea treatment: Toll-like receptor 2 inhibition in macrophages","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16525","article-title":"Carvedilol ameliorates persistent erythema of erythematotelangiectatic rosacea by regulating the status of anxiety\/depression","volume":"49","author":"Li","year":"2022","journal-title":"J Dermatol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.4c08884","article-title":"Novel thermosensitive hydrogel encapsulated carvedilol for the treatment of rosacea","volume":"10","author":"Chen","year":"2025","journal-title":"ACS Omega"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12687","article-title":"Propranolol, doxycycline and combination therapy for the treatment of rosacea","volume":"42","author":"Park","year":"2015","journal-title":"J Dermatol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12439","article-title":"Combination treatment of propranolol, minocycline, and tranexamic acid for effective control of rosacea","volume":"30","author":"Kwon","year":"2017","journal-title":"Dermatol Ther"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.cell.2026.01.036","article-title":"Metabolite-gated vascular contractility switch: OXGR1 activation mechanism enables agonist therapy for rosacea erythema","volume":"189","author":"Xiao","year":"2026","journal-title":"Cell"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.08.037","article-title":"Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee","volume":"78","author":"Gallo","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.413","article-title":"Neurogenic rosacea: A distinct clinical subtype requiring a modified approach to treatment","volume":"147","author":"Scharschmidt","year":"2011","journal-title":"Arch Dermatol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2512123","article-title":"Comparison of clinical characteristics of neurogenic rosacea and erythematotelangiectatic rosacea: A cross-sectional observational study","volume":"57","author":"Liu","year":"2025","journal-title":"Ann Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.35541\/cjd.20230451","article-title":"Insights into rosacea from the perspective of psychosomatic medicine","volume":"57","author":"Jiang","year":"2024","journal-title":"Chin J Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1876564\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:34:54Z","timestamp":1782102894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1876564\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":76,"alternative-id":["10.3389\/fimmu.2026.1876564"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1876564","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"article-number":"1876564"}}